Transcatheter Mitral Annuloplasty: Early Outcomes of Cardioband Device

24 November 2015

This study demonstrates the feasibility and safety of percutaneous direct mitral annuloplasty with the Cardioband device in high-risk patients with MR

Transcatheter Mitral Annuloplasty: Early Outcomes of Cardioband Device

The article by Dr. Francesco Maisano et al was published in the European Heart Journal (18 November 2015) and reports the early (1 month) outcomes of the first-in-man pre-CE-mark feasibility and safety trial.

The initial experience with the Cardioband system shows that transfemoral 
implantation of a surgical-like direct annuloplasty device is feasible, safe, and effective.  
Cardioband device closely reproduces surgical annuloplasty with sustained and effective septolateral reduction of the annulus and MR reduction in all patients.
This study demonstrates the feasibility and safety of percutaneous direct mitral annuloplasty with the Cardioband device in high-risk patients with MR. Acute efficacy is comparable with that observed with transcatheter edge-to-edge mitral valve repair.  
Further investigation is needed to assess the durability and the long-term outcome. This technology, based on a solid surgical background, is a promising tool to improve the results of transcatheter mitral valve interventions.   
It has the potential to expand the overall number of patients who could benefit from a transcatheter mitral intervention and to improve the efficacy and the durability of the currently available techniques, by the combination of annular and leaflet repair in selected patients.

Link to the article: http://www.ncbi.nlm.nih.gov/pubmed/cardioband_fim

« Go back